Defining the Role of Surgical Resection in Metastatic Renal Cell Carcinoma: A Mini Review
European Urology Focus · 2025
DOI: 10.1016/j.euf.2025.04.022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Urology Focus, 2025. Verfasst von Steven M Monda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Michigan Medicine, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Nephrectomy, Metastasectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Peking University Health Science Center, Prostate Cancer Foundation.
Abstract (Originalsprache)
Ongoing advances in systemic therapy for metastatic renal cell carcinoma (mRCC) have left the role of surgical resection in this setting uncertain. In this mini review, we examine historical data and ongoing clinical trials evaluating the role of cytoreductive nephrectomy and metastasectomy in mRCC. We note that patients undergoing upfront nephrectomy may have a delayed opportunity to receive systemic therapy, which poses a significant risk, particularly for individuals with poor-risk or actively progressing disease. Although patients undergoing resection after response to systemic therapy have favorable outcomes, ongoing randomized trials will provide clarity regarding the role of deferred nephrectomy and metastasectomy in the context of current systemic regimens. PATIENT SUMMARY: In this mini review, we assess data on surgery to remove the primary tumor and its metastatic sites in kidney cancer. Drug options for metastatic kidney cancer have greatly improved, so there is a need to evaluate how surgery is used for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.
- Department of Urology, Michigan Medicine, Ann Arbor, MI, USA; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
- University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA; Department of Internal Medicine, Division of Hematology & Oncology, University of Michigan, Ann Arbor, MI, USA.
- Department of Urology, Michigan Medicine, Ann Arbor, MI, USA; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA. Electronic address: usinghal@med.umich.edu.
Förderung
- NCI NIH HHS
- Peking University Health Science Center
- Prostate Cancer Foundation
- National Cancer Institute
- National Institutes of Health
- Urology Care Foundation
- University of Michigan
- American Urological Association
Zitieren
APA
Monda, S. M., Salami, S. S., Vaishampayan, U., Morgan, T. M., & Singhal, U. (2025). Defining the Role of Surgical Resection in Metastatic Renal Cell Carcinoma: A Mini Review. European Urology Focus. https://doi.org/10.1016/j.euf.2025.04.022
Vancouver
Monda SM, Salami SS, Vaishampayan U, Morgan TM, Singhal U. Defining the Role of Surgical Resection in Metastatic Renal Cell Carcinoma: A Mini Review. European Urology Focus. 2025. doi:10.1016/j.euf.2025.04.022
BibTeX
@article{Monda2025,
author = {Monda, Steven M and Salami, Simpa S and Vaishampayan, Ulka and Morgan, Todd M and Singhal, Udit},
title = {Defining the Role of Surgical Resection in Metastatic Renal Cell Carcinoma: A Mini Review},
journal = {European Urology Focus},
year = {2025},
doi = {10.1016/j.euf.2025.04.022}
}
EUVIMED